Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2009

Feb 3, 2009

29777_dirs_2009-02-02_040328ad-c965-40a6-b781-5d37e58112d3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2009-01-29

Reporting Person: LIEPMANN HOLGER A (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-01-29 Common shares without par value M 10067 $53.40 Acquired 155842 Direct
2009-01-29 Common shares without par value S 5000 $55.28 Disposed 150842 Direct
2009-01-29 Common shares without par value S 5067 $55.27 Disposed 145775 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-01-29 Option (right to buy) $53.4 M 10067 Disposed 2009-02-11 Common shares (10067) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 14183 Indirect
Common shares without par value 295 Indirect
Common shares without par value 296 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of January 29, 2009.

F2: The reporting person disclaims beneficial ownership of shares held by his daughters.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.